BREAKING NEWS: CDC Advisory Committee Recommends Pfizer’s Covid Vaccine for 12- to 15-Year-Olds
- CDC advisory committee on Wednesday recommended that Pfizer-BioNTech’s COVID-19 vaccine be administered to children 12 to 15 years of age
- With the recommendation, most states will likely start handing out the shot to younger teens on Thursday
- It comes two days after the FDA approved the Pfizer vaccine for 12 to 15 year olds for emergency use
The Centers for Disease Control and Prevention (CDC) advisory committee voted to recommend administering Pfizer-BioNTech’s COVID-19 vaccine to children ages 12 to 15.
On Wednesday, 14 members of the Vaccination Practices Advisory Committee (ACIP) voted ‘yes’ and one member withdrew.
It comes two days after the U.S. Food and Drug Administration (FDA) approved the injection for emergency use in younger teens.
The vaccine was approved for Americans 16 and older in December 2020, and Pfizer has been conducting trials for teens since October last year.
With ACIP’s formal recommendation, most states will likely start handing out the shot to younger teens on Thursday
Expanding the availability of vaccines to younger teens will make about 17 million additional Americans eligible for vaccination, a step that some consider critical to achieving herd immunity and improving safety when children return to school.
However, some parents and experts have questioned whether vaccinating children is really for their own benefit, or whether it risks the effects of a new vaccine in children to protect adults, when only 0.1 percent of U.S. Covid deaths are among people under 18.
CDC advisory committee recommended that Pfizer-BioNTech’s COVID-19 vaccine be administered to children 12 to 15 years of age
Pfizer’s Phase III clinical trial enrolled approximately 2,200 teens in the US, compared to 40,000 for the study ages 16 and older.
Half of the group received two doses of the vaccine three weeks apart and the other half received two placebo injections.
A total of 18 cases of COVID-19 were reported in the placebo group, while no cases were reported in the vaccine group.
This means that the vaccine was 100 percent safe and effective in 12-15 year olds, according to the researchers.
In addition, the side effects were similar to those in the larger trial in 16 to 25 year olds, including injection site pain, fatigue, fever, and headache.
Pfizer’s CEO, Albert Bourla, said at the time that the hope “ began to vaccinate this age group before the start of the next school year. ”
Researchers plan to follow participants for two years to gather information about long-term protections, effects and safety.
This is a breaking news story and will be updated.